China’s vaccine regulator reaches new WHO rank
WHO confirmed the country’s attainment of Maturity Level three (ML3)—the third of four levels in the WHO’s classification
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
WHO
WHO recommends use of two antibody drugs against Ebola
The drugs - Regeneron's Inmazeb and Ridgeback Bio's Ebanga- use laboratory-made monoclonal antibodies that mimic natural…
ICMR invites companies to develop vaccines, diagnostic kits for monkey pox
According to WHO, monkeypox is a viral zoonosis – a virus transmitted to humans from animals – with symptoms similar to smallpox…
Sanofi launches health brand with non-profit treatments for low-income countries
The treatments will be provided under the new Impact brand, part of Sanofi’s global health unit launched last year, which sits…
Biological E gets WHO nod to be additional facility for making Johnson & Johnson COVID vaccine
The DCGI recently approved Corbevax as a precaution dose for those aged 18 and above
WHO in process of procuring monkeypox tests for Africa, recommends vaccine readiness
The World Health Organisation (WHO) is in the process of procuring thousands of monkeypox tests for Africa but is not recommending…
Challenges in procurement of “Quality Assured” generics
Dr Suresh Saravdekar, Ex-Assistant Director, Ministry of Medical Education and Health, State of Maharashtra and Ex-honorary…
US FDA lifts hold on Covaxin’s clinical trials
The FDA's earlier decision, in April, to put on hold the trials was based on the US firm's decision to voluntarily implement a…
PM Modi seeks streamlining WHO’s vaccine approval process; calls for flexible rules by WTO
In his address at the second global COVID virtual summit, Modi, highlighting India’s role in combating the corona virus pandemic,…
Government to expedite process of recognition of Biological E Corbevax by other countries
According to an internal document circulated to the members of the Empowered Group-5 on COVID-19 Vaccination, which will be…